Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
biomedion logo — Leveraging Innovations in Life and Health Science

biomedion

Leveraging Innovations in Life and Health Science

Founded 2000 Germany Berlin, Germany 12 employees Private Equity Data Analytics, Life Sciences

General Information

Company Name biomedion
Founded Year 2000
Location Germany Berlin, Germany
Employees 12
Industries Data Analytics, Life Sciences
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with biomedion. To contact biomedion, visit biomedion.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does biomedion compare?

A PDF of biomedion and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting biomedion soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About biomedion

biomedion is a Germany-based software company that focuses on designing and developing cloud-based enterprise software for the life sciences industry. The company's flagship product, neuronOS®, is a versatile and data-driven life sciences platform which has been implemented by major biotech and pharma companies for over 10 years. The platform ensures data integrity, long-term data archiving, and hybrid architecture, and is designed to fit the F.A.I.R model and help users to be ALCOA+ compliant. In 2023, biomedion made a strategic decision to focus on raw data management, leading to the release of neuronOS® 2.0. As of the 8th of February 2022, the company received a Private Equity Round investment from Main Capital Partners, indicating strong investor confidence in the company's direction and potential for growth. Founded in 2000, biomedion has established itself as a market leader in providing data-driven solutions for the life sciences industry. The company offers a cross-functional product portfolio for managing data integrity from raw data, quality, clinical, and regulatory processes towards retention and archiving. With over 5,000 users, the success of biomedion and its neuronOS® platform demonstrates a strong track record of providing valuable solutions to the industry.

Business keywords: Life Sciences, Cloud-based Software, Pharmaceutical Industry, Data Integrity, GxP Standards, Raw Data Management, Enterprise Software, Archiving Solutions

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Main Capital Partners
Main Capital Partners
08 Feb 2022

biomedion Alternatives & Competitors

View All Alternatives
biomedion vs
ONTOFORCE
ONTOFORCE Belgium

Through our data and technology solutions, we transform data into actionable insights, and streamlin...

Series A
37 employees
Analytics, Biotechnology
biomedion vs
MAASI Enterprises
MAASI Enterprises United Kingdom

Qualified advisory & consultancy for the life-science industry. Experience Matters!

48 employees
Analytics, Automation
biomedion vs
Tego, Inc.
Tego, Inc. United States

Powering Assets with Intelligence

Venture round
18 employees
Data Analytics, Industrial
View all alternatives

FAQ About biomedion

Leveraging Innovations in Life and Health Science
biomedion was founded in 2000.
biomedion is headquartered in Berlin, Germany.
biomedion operates in Data Analytics and Life Sciences. Its work centres on Life Sciences, Cloud-based Software, Pharmaceutical Industry and Data Integrity.
biomedion has approximately 12 employees.
biomedion has completed 1 funding round. The latest funding stage is Private Equity.
Top alternatives and competitors to biomedion include ONTOFORCE, MAASI Enterprises, Tego, Inc., Biomage Ltd, PHEMI Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
biomedion and ONTOFORCE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for biomedion, https://bouncewatch.com/company/biomedion, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout